about
Hematopoietic stem cells in research and clinical applications: The "CD34 issue".Busulfan administration flexibility increases the applicability of scid repopulating cell assay in NSG mouse model.Interleukin-3 and ex vivo maintenance of hematopoietic stem cells: facts and controversies.Hypoxia or in situ normoxia: The stem cell paradigm.Physiological, ex vivo cell oxygenation is necessary for a true insight into cytokine biology.Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen.Discarded leukoreduction filters: a new source of stem cells for research, cell engineering and therapy?Oxygen concentration influences mRNA processing and expression of the cd34 gene.Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia.Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells.High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasma.In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.Low O2 concentrations enhance the positive effect of IL-17 on the maintenance of erythroid progenitors during co-culture of CD34+ and mesenchymal stem cells.Functional stability (at +4°C) of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy.A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.Respect the anaerobic nature of stem cells to exploit their potential in regenerative medicine.HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.Variations of factor VIII:C plasma levels with respect to the blood group ABO.Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%).Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors.Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood.Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters.[Oxygenation level as a factor in stem cell maintenance].Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantation.Comparison of CD34+ cell collection on the CS-3000+ and Amicus blood cell separators.CD34+ cells obtained from "good mobilizers" are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from "poor mobilizers".Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells.Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity.The majority of cells in so-called "mesenchymal stem cell" population are neither stem cells nor progenitorsConstitutive production of regulators of stem cell proliferation in the hereditarily anaemic belgrade laboratory (b/b) ratErythroid progenitor cells from pig bone marrow and peripheral bloodStimulator of proliferation of spleen colony-forming cells in acute sterile inflammationPrimitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percentPluripotent haemopoietic progenitor cells (CFU-Sd8) in peripheral blood of hereditarily anaemic Belgrade (b/b) ratsAngiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented mediumAn efficient large-scale thawing procedure for cord blood cells destined for selection and ex vivo expansion of CD34+ cellsLarge-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacityInterleukin-6 (IL-6) and low O(2) concentration (1%) synergize to improve the maintenance of hematopoietic stem cells (pre-CFC)
P50
Q34992263-F69B86B7-C8BE-4A70-B599-57CC22C94A79Q34999133-F78C7A0B-4C36-4E2A-AFF9-B14310DE8D3AQ35817459-C92E939D-C904-46F0-BE9C-2F167416C458Q37374626-FD3FE31D-0E6A-4D7A-8B69-F8189A8BBD23Q37422787-66220824-3CF1-4346-BC54-132AFDD2C16EQ37765040-FF5D5E87-1138-4938-88DE-C10F7E9B7340Q38112544-895976BB-B058-4F79-8C4E-F1271697763CQ40371200-C1150B45-6F61-4F99-B728-698E02BF92A2Q43711638-EFC709A6-226E-42A5-AC53-7C8D520C68D1Q43873784-31648882-598F-4C5F-B12D-8631E7E6586DQ44355414-2CFFEC61-CCE2-459E-9E11-05E624B00CE2Q45108187-26715C05-3D19-49C9-AA08-67738BE61EA4Q46046357-20654345-B4BC-4318-AD0E-FC0720E9A3B5Q46076391-6621EF1B-017D-4AAF-A378-7B460C61F4BFQ46172001-08F92681-54FD-4802-BD8C-DC689C7049DFQ46883912-E02586D2-D37F-4AE6-916F-9A6F0D72E9D5Q46883914-C4CE244B-0371-44C2-9A95-5BD61004F0DCQ46979782-6A2C53D9-1D07-4464-A013-B8AB686BEEE0Q46986973-6A213741-549C-4BD3-8095-E3A23096CF0AQ47686390-8C684ECE-31D8-4184-BC9E-BE4E2A464E65Q47932659-B177544F-A008-4669-8B9C-E8FBF3B1C41FQ49049477-34B63B69-E02E-4C46-BD64-7FB7C1C237BBQ50491458-BBEE4623-1B96-47F5-8AA6-CB4A3952DD38Q50578062-D504B426-A792-495D-889C-4E77910941EBQ50730765-7B14AD6B-0EAB-4273-9140-1412B15DD838Q51797330-A2681B57-342F-49DC-912A-9058BC827F55Q51821090-9DCDE7D7-7942-43C7-A757-43960394AF43Q53366185-3412EB0A-28CF-48F5-BAC8-906523C61B7DQ53659800-BC8489C2-0E60-44FA-ABFE-320725813AE1Q54615281-76DE6F4C-6AF4-4835-97B1-41AC5272E252Q58564385-0D96344E-B0C4-463E-AE18-F253BF676B87Q59091422-443738C6-7224-4974-94A2-4E0FC9C28819Q73175320-95C37E5A-C833-4465-A226-C755E2D87E9DQ73259970-216B8C17-D311-4872-8303-E74D45B79C48Q73337460-F7B0473D-D72E-495A-913E-98E1AF361781Q73663396-1B1A9582-C8F4-49A1-99DC-F5F8128D2655Q74066251-AAA75B7E-EF4F-489F-A1BA-22CEBC4FEB79Q79241080-6CEF01B4-9191-4C5D-AB3F-23AB91C26D2DQ79319266-6B9C42A5-4B74-4B75-82ED-8EE8B63EA3ABQ79801688-D01972E7-D1B1-4795-A172-B0543A56C946
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zoran Ivanovic
@ast
Zoran Ivanovic
@en
Zoran Ivanovic
@es
Zoran Ivanovic
@nl
Zoran Ivanovic
@sl
type
label
Zoran Ivanovic
@ast
Zoran Ivanovic
@en
Zoran Ivanovic
@es
Zoran Ivanovic
@nl
Zoran Ivanovic
@sl
prefLabel
Zoran Ivanovic
@ast
Zoran Ivanovic
@en
Zoran Ivanovic
@es
Zoran Ivanovic
@nl
Zoran Ivanovic
@sl
P106
P21
P31
P496
0000-0001-6158-0270